Sol Barer, Ph.D.
Dr. Sol Barer has served on the Edge Therapeutics, Inc. Board of Directors since September of 2011 and is the current Board Chairman and Chair of Compensation Committee. He is the Managing Partner of SJ Barer Consulting and was the founder of the group at Celanese that spun out to form Celgene Corporation. Dr. Barer has spent 18 years leading the company as President, COO and CEO, culminating with his tenure as Celgene’s Executive Chairman and Chairman before retiring in June of 2011. Under his leadership, Celgene became the third-largest independent biotechnology company in the world and a member of the S&P 500.
Dr. Barer has more than 30 years of experience with publicly traded biotechnology companies including product development, scientific and business strategy, manufacturing, marketing and the building of an international company. He currently serves as on the Board of a number of other biotechnology companies including Amicus Therapeutics, Inc. and Aegerion Pharmaceuticals, Inc. Dr. Barer is Chairman of the Board of Centrexion Inc., Cerecor, Inc., ContraFect Corp., InspireMD, Inc., Medgenics, Inc. and RestorGenex.
Dr. Barer holds a B.S. from Brooklyn College. He earned his Ph.D. in Organic and Physical Chemistry from Rutgers University.